Business
GraftBio IP - MGC Pharma Update
GraftBio IP - MGC Pharma Update.
About this update from Solvonis Therapeutics Plc
[{"type":"text","content":"\n \n \n \n \n \n \n \n \n 17 June 2022\n \n \n Graft Polymer (UK) Plc\n \n \n \n \n \n \n \n (\"Graft Polymer\", the \"Company\", and together with its subsidiaries, the \"Group\")\n \n \n \n \n \n GraftBio IP - MGC Pharma Update\n \n \n - \n Graftbio's Platform used in MGC Pharmaceuticals Successful\n \n \n \n - \n \n Glioblastoma Pre-clinical Trial Results\n \n \n Graft Polymer (UK) Plc (LSE: GPL), a business focused on the development and commercial production of polymer modification, biological supplements, and nano-drug delivery systems, is pleased to note the announcement issued by MGC Pharmaceuticals Ltd (LSE:MXC, ASX:MXC, \"MGC Pharma\") on 16 June 2022, regarding MGC Pharma's use of a base formulation nano delivery system, based on Graft Polymer's GraftBio IP, in relation to a pre-clinical research study in the use of cannabinoids to treat Glioblastoma multiforme cells, a fast-growing and aggressive form of brain cancer.\n \n \n \n \n \n MGC Pharma, which uses Graft Polymer's drug delivery platforms in relation to MGC Pharma's CimetrA™ and CannEpil-IL™ products, confirmed that it has undertaken studies relating to the application of a base formulation nano delivery system, founded on the Company's GraftBio IP, to improve the bioavailability of the active compounds using a non-invasive drug administration process. The study examined the toxicity of the base emulation to confirm its safety profile for potential use in future clinical research.\n \n \n \n \n \n Victor Bolduev, CEO, commented:\n \n \n \n \n \n \"This important work being conducted by MGC Pharma, which is supported by Graft Polymer's GraftBio IP, is a real-world example of the enormous value of the research that we are undertaking. Treating fatal cancerous brain tumours through the application of naturally derived cannabinoid products would be the definition of life-changing for so many people, and I am proud that Graft Polymer is such a critical partner in this effort.\" \n \n \n \n \n \n \n For more information, please visit \n \n \n \n https://www.graftpolymer.com\n \n \n \n or contact:\n \n \n \n \n \n \n \n \n \n \n \n Graft Polymer (UK) Plc\n \n \n \n \n \n via Tavistock\n \n \n \n \n \n \n Roby Zomer, Chairman\n \n \n \n \n \n \n \n \n \n \n \n \n \n Yifat Ste...